Announcement
Super Grannies and Market Update – June 30 Webinar Cancelled

7D Delta Turns Positive, Market Chop Way Paves Way For Rally

Daily cases unfortunately have returned to slightly positive coming in at 58,468 which is up 2,869 cases from a week ago. The 7D positivity rate declined to 4.4% from 4.5% 7D ago. Importantly, hospitalizations and deaths are still moving in the right direction and are down 5.1% and 7.4% from 7 days ago respectively. Dr. Fauci said on Friday that up to 30% of the new US cases are due to the variants. Luckily, despite the vaccines not being as effective against some of the newer COVID-19 variants

Daily cases unfortunately have returned to slightly positive coming in at 58,468 which is up 2,869 cases from a week ago. The 7D positivity rate declined to 4.4% from 4.5% 7D ago. Importantly, hospitalizations and deaths are still moving in the right direction and are down 5.1% and 7.4% from 7 days ago respectively. Dr. Fauci said on Friday that up to 30% of the new US cases are due to the variants. Luckily, despite the vaccines not being as effective against some of the newer COVID-19 variants it still appears to prevent severe illness and hospitalization to the degree that it would mean the risk for overwhelming the hospital system which we may forget after all this time is still the primary reason for lockdowns that interrupt economic activity much lower. Be sure to check out point #3 in our dailies that monitors the progress in re-opening across the United States.

...

Finish reading this report for free

Enter your email and we’ll send the paywall-free link directly to your inbox

In addition to your unlocked report, you will receive our weekly market newsletter FSI Snapshot, as well as occasional updates and offers from FS Insight. You can unsubscribe at any time. For more information, see our privacy policy.

Get unlimited access to Tom Lee’s Fundstrat research Subscribe
Already a member? Log in

More from the author

Disclosures (show)

Get invaluable analysis of the market and stocks. Cancel at any time. Start Free Trial

Articles Read 2/2

🎁 Unlock 1 extra article by joining our Community!

You are reading the last free article for this month.

By continuing, you agree to the Terms of Service and Privacy Policy.

Already have an account? Sign In

Trending tickers in our research

Get invaluable analysis of the market and stocks. Cancel at any time. Start Free Trial

Articles Read 2/2

🎁 Unlock 1 extra article by joining our Community!

You are reading the last free article for this month.

By continuing, you agree to the Terms of Service and Privacy Policy.

Already have an account? Sign In